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Aujeszky's disease (AD) is an important disease affecting the swine industry 
in many countries. An eradication catnpaign was officially applied in September of 
1994 in Northern Ireland. The current eradication scheme was investigated. 
Two main groups of herds were identified from an existing computed 
database and were classified as: group A, herds that changed their health status, and 
group B herds that did not change their health status. Herds within each group (A and 
B) were also classified according to their health status into two groups: a) Otliers,
herds that were neither infected nor vaccinated and regarded as free of the disease, 
and b) PS's, herds that were either vaccinated and/or infected. 
The eradication scheme in Northern Ireland is making progress. The linear 
regressions on months were significantly for the number of herds (F=29.14, P<0.05), 
and the high health status OADF (F=9 I .5, P<O.O I) and ADF(F= I 67 .8, P<0.00 I). 
More herds had higher health status in tl1an before. Infected herds decreased from 25 
% to I 0.7 % after two years. In addition the pig industry expanded with new herds 
being registered, although their disease status has yet to be assessed. 
The groups of herds were analysed by region, current status, herd type and pig 
population The main significant difference in the number of herds was found for the 
compar1')ons bet\veen the groups 1) Otl,ers and PS's (X
2= 116.9, P<0.001 ), 2)
PS I +PS2 and PS3+PS4 (X
2=3 73, P<0.05), and 3) PS 1 +PS3 and PS2+PS4 (X
2=5.68,
P<O O 1) of group A and group B v.,hcn compared together It wa� 1dent1f1ed that the 
most important region� 1n term� of number of 1nf ccted herds, ptg population and new 
herds a,vaiting clLiss1f 1cation of their hcallh slatu-.. ,vere UK3 and UK4 where 1nore 































Aujeszky' s disease (AD) or pseudorabies is a contagious disease of pigs 
which affects the respiratory tract, as well as the central nervous and reproduct1 ve 
systems. AD is caused by a porcine herpesvirus I, family Herpesviridae, subfamily 
Alphaherpesvirinae. The economic losses are due to high mortality in new-born 
piglets, reproductive failure and respiratory problems in growing pigs which delay 
the time for slaughter. 
The disease has been related to areas with high density of pigs, and can be 
attributed to the intensification of production over the last 20 years. AD can affect 
swine herds for a long time because after infection the virus tends to become latent 
and after reactivation, the virus can be shed and transmitted to susceptible animals. 
Pigs are the major host for Aujeszky' s disease virus (ADV) and are the source of 
infection to other animal species. 
Control and eradication programmes against AD are currently actjve in many 
countries using different strategies such as depopulation-repop·ulation, test and 
removal, offspring segregation, and most i1nportant vaccination with gene-deleted­
vaccines that, together with the complementary serologica] tests, allow the 
diff erentiat1on of vaccinated from naturally infected pigs. It is thought that vaccines 
reduce the c1Jn1cal presentation of the disease and the amount of virus excretion, thus 
eventually reducing the viru5 circulation on pig farms. 
Control programmes of AD in many countries have the goal of ach1ev1ng 
eradication not only because of herd econom1c losses but also to enable with














Northern Ireland is one of the countries where an intensive vaccination 
programme with deleted-vaccines together with regular serologic monitoring has 
been officially applied since September of 1994. 
The objectives of this study are: 
-To review the geographic distribution of AD in Northern Ireland according
to DVO region and pig density areas. 
-To review the advances of the AD scheme in Northern Ireland after three
years of compulsory vaccination programme. 
-To find differences in the number of herds between the group of herds that





2.1. The biology of Aujeszky's disease virus 
2.1.1. Description of the virus 
2.1.1.1. Morphology 
The virus is 150-180 nm in diameter, consisting of a DNA of 75 nm diameter, 
a nucleocapsid of I 05-110 nm with 162 capsomeres. It is an enveloped virus with 
glycoproteins which are responsible for its immunogenicity (Taylor, 1995). 
2.1.1.2. Pathogenicity 
The first sites of replication of the virus are the nasal cavity, tonsils and 
pharyngeal mucosa (Vann1er, 1987). The virus is present in the oral and nasal 
secretions after infection. After replication in the upper respiratory tract 1t is found 1n 
the central nervous system where it causes a non-suppurative meningitis (Maes, 
Kan1tz, and Gustafson, 1983) Cowdry type A 1nlranuclear inclusion bodies are also 
produced (Baskerville, Mcferran, and Dow, 1973). The excretion of the virus may 
la�t 10 to l 4 day� The antibody response is seen 1n serum between 6 to 10 days after 
infection (Van 01rschot, 1994 ). 
Porcine herpesv1rus can replicate 1n pigs even if they have spec1f1c cell-bound 
antibod1e'> Jga1n�t the v1ruc; However 1n order to do so, the doc;e of viruc; has to be 
higher thJn thJl needed to infect a fully su'>cepttble Jn1n1al (Smith, 1990).
.Alveolar macrophJgec, infected with ADY d1m1n1<;h their effective Jct1v1ty. 
Other factors that LOntr1bute to the �uppression of the immune \yc,tem are the ly\1\ of 
lymphocytes, focal necrosis in lymph nodes and interference 1n the �ynthes,� of IL-2 





































others, 1993; Hall, Weigel, Siegel and others, 1991). This accounts for a higher 
susceptibility to secondary bacteria] infections (Elbers, Tielen, Cromwijk and otlzers,
1990; Fuentes and Pijoan, 1987; Muneer, Farah, Newman and others, 1988; 
Chinsakchai and Molitor, 1994). 
The virus may infect the uterus causing abortjon, foetal death and 
mummjfication. Affected boars may shed the virus in semen. 
The severity of the disease is influenced by the route of infection, strain, 
amount of virus, immune status and age of affected pigs. Low virulent strains are 
characterised by causing subclinica] infections, whereas high virulence strains in a 
susceptible population usually results in a dramatic clinical picture of reproductive 
failure where mortality in young pigs can reach 100 per cent, although mortality in 
fattening pigs is generally less than 5 percent (Taylor, 1995).
Pigs recovered from AD wild virus infection are immune but may act as 
carriers since the virus tends to latency, an i1nportant feature of ADV (Van Orischot, 
1994; Brown, Osorio and rock, 1990) . 
2.1.1.3. Transmission 
Pigs are the main host for ADY but they may spread the disease to other 
susceptible species. 
Transmission 1n pigs is by direct pig-to-pig contact when nasal discharges and 
saliva contain the cell-bound virus, and the main source of 1nfect1on is from 
asymptomatic carrier animals (Donaldson, Wardley, Martin and Ferris, 1983). Air 
borne transm1ss1on plays an important role 1n the spread of the disease (Christensen, 
Mou!)tng, Mortensen and otlzers, 1990; Mortensen, Mousing, Henriksen and otlzers,


























decreased up to 50 per cent in less than one hour when the virus was exposed to 20
°C 
and 85 per cent RH. Conversely the survival of the virus in aerosols was increased at 
4°C and 55 per cent RH showing that environmental conditions might play a role 1n 
the in the viability of ADV. Other ways of spread are mechanical transmission by 
inanimate objects such as syringes, needles, boots and vehicles. 
In epidemiological terms, transmission can be quantified by a reproduction 
ratio (Ro) which is defined as the mean number of hosts that become infected by one 
infectious individual. A minor outbreak of disease is considered when Ro<l, only a 
fev1 animals becoming infected. If R0> 1 then the infection is regarded as a major 
outbreak. The bigger the Ro the harder the eradication, but if R0< 1 in a certain 
population or area, then eradication may be achieved (Diekmann, Heesterbeek, and 
Metz, 1990). In other words, a focus of infection with value R0=0 cannot maintain 
and spread itself. In a comparison of two different diseases, rubella and measles in 
the US, one having bigger Ro (measles) than the other (rubella) before vaccination, it 
was shown that rubella was certainly eradicated after a compulsory vaccination 
programme whereas the incidence of measles was only considerably reduced. This 
example showed the importance of the Ro value in intensive vaccination programmes 
(Anderson and May, 1983).
A study carried out by the United States Department of Agriculture (USDA) 
1n 1991 reported that in more than 50 per cent of outbreaks of AD the source of 
1nfect1on was not identified (AnneJ1i, 1991 ).












The mechanisms for attachment and penetration of ADY into the ce]l involve 
different proteins such as gT, gII, gIIl, gp63 gp50 and gX (Robbins, Watson, Whealy 
and ot/1ers, 1986a). The genes encoding for their synthesis have been identified. The 
biological function of such proteins is described in table I. The analysis of the 
genetic sequence has demonstrated that the glycoproteins of ADY are homologues of 
the ones that are found on the surface of the Herpes simplex virus (HSV), e.g. 
glycoprotein gll of ADY is the homologue of gB of HSY and gIIl of ADV is the 
homologue of gC of HSV (Robbins, Whealy, Watson and ot/1ers, 1986b; Wathen et 
al, 1986; cited by Ben-Porat, Demarchi, Lomniczi and others, 1986) (Table 2). The 
gill is one of the non-essential proteins for virus growth i11 vitro, but its role is 
important in the adsorption of the virus to the cell (Karger and Mettenleiter, 1993 ). It 
has been suggested that gill participates directly in such phenomena or at least it 
interacts with other viral proteins of the protein complex such as gII and gp50 
triggering the adsorption penetration into the cell (Zuckerman, Laszlo and Reilly, 
l 989).
One of the n1ost important ADY proteins for immunogenicity is gIIl, since the 
avidity of serum f ron1 convalescent pigs to target cells that have been infected with 
deleted strain (gill-) is less than hyperimmune serum directed to gIIl. On accordance 
with th1s the neutralising acti v1ty of antibodies against ADY seems to be directed to 
g!Il. Th,� point has to be taken into account 1n the production of gene-deleted 
vaccine!) (Zuckennann, Laszlo and Metteinliter, 1990; Ben-Porat et al, 1986). 
on'lidering tJ1ut the cellular n1ediated 1111mune response b)' lymphocyte� T 
cytotoxic 1s directed to gil , celJ� expressing gill as antigen are the main target for 
effector cell�, \vhercas other gl)1coprotc1ns like gI, gpill and gX ant1gen-expres51ng




















the immunogenicity, a study was carried out by Pensaert, Gielkens, Lomniczi and 
otl1ers (1992) using monoclonal antibodies (MAbs) showed that MAbs directed to 
gll, gill and gp50 neutralised ADV with or without complement, whereas MAbs 
directed against gl required complement to neutralise the virus. On the other hand 
glycoprotein gX did not induce neutralising antibodies. Table 3 shows the role of 
glycoproteins in the immunogenicity for B and T cells, the induction of protection 
and the action of MAbs. 
2.1.2.2. Cell-mediated immune response 
The main effector cells of the immune response against ADV are cytotoxic 
lymphocytes. These cells are responsible for killing viral-infected cells since they 
recognise viral antigen proteins that are expressed together with major 
histocompatibility complex (MHC) class I and class II. The former seems to be 
related to lymphoproliferation through CDs+ as a response to live virus (Kimman, 
Bianchi, De Bruin and others, 1995a). Some studies have indicated that the 
expression of MHC class I can be regulated by the virus (Mellencamp, O'Brien and 
Stevenson, 1991 ). However other studies have shown that neither MHC class I nor II 
are regulated by ADV infection at all (Kimman, Bianchi, De Bruin and ot/1ers,
1995c). 
Detection of interferon is possible about 48hrs post infection (Krist1en and 
Pen�aert, 1995). The importance of gamma-interferon is related to the activation of 
lymphocytes. Once infected cel1s have expressed the viral antigen proteins, they
becon1e su�cepl1ble r or Jysis by activated lymphocytes If lymphocytes are not
acL1vated bccau�e gamma-interferon is not present, then their killing activity 1�
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The proliferation of T lymphocytes is followed by the production of 
lymphokines such as interleukin 2. These are responsible for the induction of 
lymphokine activated-killer cells (LAK) which are responsible for killing ADY­
infected target cells (Vanderpooten and Goddeeris, 1995, Kimman et al, 1995c). 
The identification of the cells that are involved in the lymphoproliferation 
against ADY was shov1n by using monoclonal antibodies (MAbs) directed to CD2 +, 
CD4 + and CDs+ . The most important cells were CD8 + followed by CD4 + (K.imman, 
De Bruin, Voermas and ot/1ers, 1995b ). 
Pigs experin1entally inoculated with live virus showed lymphoproliferation 
seven days after inoculation. After a second challenge, the lymphoproliferation could 
be detected as early as two days, indicating the consequence of induction of memory 
T cells as an anamnestic proliferation (Kimman, 1992). Unfortunately immunity 
against hcrpesvirus 1s not life-long and after a period of time the virus may replicate 
again from latent infections (Kimman, De Wind, De Bruin and otlzers, 1994). 
2.1.2.3. Antibody-mediated immune response 
The humoral immune response against ADV is featured by the production of 
antibodies aga1 nst virus g)ycoproleins (Mellencamp et al, 1991 ). IgM appears in 
serum and secretions at about 6 to 8 days post vaccination (dpv), followed by IgG I 
between l O and I 3dpv and IgG2 at about 13 to 20 dpv. The production of IgA in 
�erum, howevt!r, tend5 to be n1orc irregular although not in secretions, since it is the 
second most 1mporranl immunog)obulin after IgM, appearing around I O to 13 dpv in 
a primary immune re�pon�e. Tl1e durat1on of high levels of IgG 1 and IgG2 in !)erum 
may la!)t up to thret! 1nonth1:,, whereas 1n !)ecretions IgA may be detected for as long as 







































response the production of IgG I and IgG2 in serum is quicker, as early as 3 to 6 days 
post infection (dpi) and stronger, but nevertheless, IgA is the most important 
im1nunoglobulin in secretions (Van Zaane, Browers, Van Oirschot and oth.ers, 1989; 
Martin, Wardley and Donaldson, 1986). The role of local immunity (IgA secretory) 
was demonstrated in a study where surviving pigs from first ore-nasal (ON) 
experimental challenge did not show a significant cytotoxic activity in peripheral 
blood cells, suggesting that at the second ON challenge the local immune response 
was strong enough to neutralise the virus in sitit (Vanderpooten et al, 1995). 
Sometimes pigs do not show a secondary antibody response because T cell 
proliferation suppresses the B cells response by activation of cytotoxic cells, gamma­
interferon and tumour necrosis factor (TNF). These factors contribute to eliminate 
infected cells very quickly and efficiently resulting in poor stimulation of B cells 
(Kimmann, De Bruin, Voermas, 1996). This explains the fact that protection of pigs 
against virulent virus after being pre-exposed to the virus may be seen despite low 
levels of antibodies, indicating the important role of cell immunity (Wittmann et al,
1976 cited by Vannier, Hutet and Cariolet, 1995; Pensaert et al, 1992). 
2.1.2.4. The role of maternal antibodies 
The presence of maternally derived immunity must be taken into account 1n 
the designing of vaccination schedules, since it has been suggested that passive 
antibodies interfere with the developn1ent of active immune response to vaccine virus 
(Vann1er et al, 1995). However, the importance of colostral immunity for protection 
was demonstrated when pigs having high levels of maternal ant1bod1es survived
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Kimman ( l 992) observed the interference of maternal antibodies in the 
im1nune response when pigs inoculated intra-nasally (IN) with virulent strain only 
showed production of IgM in serum and no response was observed in pigs inoculated 
with avirulent or inactivated vaccine strains. A secondary antibody response was 
produced only in pigs inoculated with vaccine strains, although higher titres of IgA 
were developed from pigs IN inoculated suggesting that despite the presence of 
maternal antibodies pigs can develop an immune response to virulent but not to 
avirulent or attenuated virus. Maternal antiborues partially suppress an active 
immune response by negative feed-bac.k of existing IgG (Kimman, 1993), unless a 
booster dose of vaccine is given (Van Oirschot, Moorman, Berns and otlzers, 1991 ). 
It was found that the best results occurred when a booster was applied at 16 weeks of 
age giving it a better chance to overcome maternal antibody interference (Weigel, 
Lehman, Herr and ot/1ers, 1995). 
Studies showing the difference between immune responses of pigs with or 
without circulating maternal antibodies were carried out by (Vannier et al, 1995; 
Kimman, 1993). Maternal antibodies tend to disappear from systemic circulation at 
about l Oto 12 weeks of age (Van Oirschot and Gielkens, 1987; Kit, 1990). 
2.1.3. Latency 
ADY is a herpes virus and one of the character1st1cs of herpes viruses 1s their 
capacity to cause latent 1nfect1ons. Many studies have been carried out to better 
understand this particulanty of herpes viruses which accounts for 1t� persistence the
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Pigs of any age that survived infection may become latently infected, acting 
as carriers that apparently look healthy. The amount of excreted virus from pigs that 
have experienced reactivation is enough to infect susceptible animals (Mengeling, 
Larger, Volz and others
'-
1992). 
The n1ain tissues associated with latent infection are the trigeminal ganglia 
and the tonsils (White, Cicci-Zanella Galeota and others, 1996; Brown et al, 1990 
cited by Chinsakchai et al, 1994). The virus was readily detectable by the polymerase 
chain reaction (PCR) technique for as long as 27 months after experimental infection. 
Detection of latent infection in different tissues using PCR is shown in table 4. 
Reactivation of latent virus was achieved by Cowen, Li, Guy and others (1990) after 
the application of dexamethasone (2mg/kg body weight) to animals belonging to 
herds with history of AD for five years which had been vaccinated with either 
inactiva.ted or modified live virus (ML V) vaccines. The tonsils were the most 
successful site for virus recovery. 
Piglets of dams with high titre of antibodies are susceptible to wild-type virus 
and may become carriers despite having high titres of maternal antibodies when 
treated with dexamethasone (Mengeling, 1989). 
It has been suggested that latency-associated transcripts (LATs) are expressed 
1n the CNS (Priola et al, 1990 cited by Chinsakchai et al, 1994), and the virus may be 
found after reactivation in non-nerve t1ssues such as tonsils which are a common site 
for virus replication. 
2.1.4. Virus excretion 
V1ru'l circulation is more likely to be found 1n areas where the ptg population 
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virus may be influenced by strain and route of infection since the ef
f
iciency of the 
immune response either locally or systemically will limit this event. In the field, the 
length of time virus excretion may last longer since infection does not occur at the 
same time in all animals and the immune status of the herd may limit such 
phenomena. 
Under experimental conditions the virus excretion lasted for 10 to 14 days 
(Van Oirschot, 1994). 
Virulence is a determinant fact: a study reported that pigs inoculated with a 
virulent NIA-3 strain shed more virus than those inoculated with a mildly virulent 
SterkseI strain (Kimman, 1993). Conversely when these strains were inoculated into 
pigs vaccinated with the 783 vaccine strain, the virus excretion of pigs challenged 
\Vith the milder Sterksel strain was higher than that from those challenged with NIA-
3. A possible explanation of these results was the known relationship between 783
strain and NIA-3, the former was stronger because its derived from the latter (Bouma, 
1996). 
Molecular techniques have been applied for the purpose of diagnosis. For 
example, to detect latent infections caused by ADY, Mengeling et al ( 1992) 
suggested the application of the PCR technique in eradication programmes of AD for 
detection of latent infections in tonsilar biopsies. 
Unfortunately, vaccines cannot stop virus excretion (Pensaert, De Smet and 
De Waele, 1990; Vannier et al, 1995� Vannier, Hutet, Bourget I and others, 1991; De 
Jong and K1mman, I 994) although 1t has been reported that the amount of virus 
excreted from vaccinated pigs can be up to I 00 to I 000 fold less than non-vaccinated





























Vaccines of AD have played a major role in control and eradication programmes in 
many countries. Differences in the efficiency between vaccines however, have been 
reported (Vannier et al, 1991; Pensaert et al, 1992). 
2.2.1. Conventional vaccines 
Conventional vaccines may interfere with the diagnosis of the disease because 
we are not able to differentiate vaccinated from infected pigs. In 1987 the use of 
deleted-vaccines lacking genes coding for expression of glycoprotein I (gD instead of 
conventional vaccines was proposed (Van Oirschot et al, 1987), which permitted 
differentiation 
2.2.2. Killed vaccines 
Killed vaccines are safer lhan MLV vaccines because they do not replicate in 
the animal, although the immune response to this type of vaccines is not as good as 
that reached with ML V vaccines (Vannier et al, 1995).
2.2.3. Gene-deleted-vaccines 
Gene-deleted AD vaccine'> and the complementary serological lest that are 
able lo different1t1Le infected from vaccinated pigs are unique 1n veterinary and 
human medicine. The u1.,e of the1.,e vaccines coupled with the current knowledge of 
the biology and epide.miology of ADY mak.t th1� d1'leJ..�e a cJndid4.lte for cradicJt1on 
Some. of the glycoproteins of ADY that have been 1.,0 f J.r 1dent1f1ed up to now 
































Oirschot, Gielkens, Moorman and ot/1ers, 1990). For example, it has been possible to 
develop deleted-vaccines lacking of the genes coding for gI, gill, TK, gX a .nd gp63. 
For instance in the Bartha strain the genes encoding gl and gp63 are deleted and the 
inactivation of these deleted proteins have reduced the virulence for pigs (Van 
Oirschot, 1994). The 783 strain, derived from the highly immunogeruc NIA-3 allows 
the differentiation between vaccinated and infected pigs (Van Oirschot et al, 1991 ). 
However, manipulations of these glycoproteins may interfere with the 
irnmunogenesis and replication of the virus in vaccinated animals since some 
glycoproteins are more important than others (Van Oirschot et al, 1990). For instance 
TK is not essential for virus growth in tissue culture, but it is important as a virulence 
determinant promoting virus replication in non-dividing cells e.g. nerve cells 
(Pensaert et al, 1992). 
The success of gene-deleted vaccines has been due to the selection of the 
most important glycoproteins which are consistent and efficacious markers for 
differentiation. 
All the current deleted-vaccines have been evaluated in pigs, and the results 
have shown that these types of vaccine are more consistent than conventional vaccine 
types. We still do not know which deleted-vaccines are best since different factors 
such as breed, age, dose, period of time between vaccination and challenge, virus 
\train and deleted protein, route ot administration and method of evaluation may 
influence this performance (Van O1rschol et al, 1990; Osorio, 1995). Today there are 
a wide range of vaccines commerciaJly available with different combination of 




















There is a general concern about the Jikelihood of virus recombination 
between MLV and wild-type virus in the field, although MLV vaccines have been 
applied in many countries in intensive vaccination programmes for a long time and 
no recombination has been reported so far. The risk of recombination is relatively 
low because genetically engineered gene-deleted vaccines lack virulence genes, 
although this risk cannot be ignored. Theoretically, recombination seems feasible, but 
to make possible the excl1anging of genetic material both viruses must infect the 
same cell at the same time which is quite unlikely since cellular receptors may be 
blocked already by the fust infected virus. 
Another point that supports the idea of low risk of recombination was argued 
by Donaldson ( 1984) who stated that the replication of attenuated vaccine virus was 
restricted just to the site of application (e.g. neck region) and no vaccine virus was 
shed in natural secretions after vaccination. 
Van Oirschot ( 1992) suggested that gene-deleted vaccines must manifest 
absence of: 
-vaccine virus transmjssion
-reactivation of latent vaccine virus
-recombination with other ADY strains
-pathogenicity for non-porcine host
-establish,nent ,n the pig population
rn order to diminish the risk of recomb1nat1on.














An ideal vaccine for the control of AD should be ab]e to: induce both 
humoral- and cell-mediated immune responses; completely reduce virulent virus 
excretion; allow the proper differentiation of vaccinated from infected pigs, and 
prevent latent infections (Pensaert et al, 1992). 
The goal of AD vaccines is to prevent the circulation and perpetuation of 
wild-type virus. It was known that a]I vaccines against AD were not able to prevent 
this. However new studies have demonstrated that deleted-vaccines with higher 
colonisation avidity (Strain SMB gX-, TK-, and gl+) are able to prevent infection 
with wild-type virus by pre-colonisation tissues targeted in latent infection e.g. 
trigeminal ganglia (Osorio, 1995). 
2.3. Vaccination 
Vaccination as a measure of control of AD has been widely used throughout 
the world for several years. At the moment many countries such as Northern Ireland, 
The Netherlands, Germany, France, Mexico, USA and others are using this approach 
to eradicate the disease. 
Vaccination has two main purposes: a) to protect individuals against the 
clinical presentation of the disease 1.e. individual immunity; and b) to reduce the 
chance of becoming infected when the individual is part of a vaccinated population 
1 e herd immunity. The achievement of herd immunity after vaccination i!) more 
desirable than 1nd1vidual 1mmun1ty and is a good indicator of the efficacy of 
vacc1nat1on (De Jong et al, 1994).
Although vacc1nat1on does not entirely prevent 1niect1on, 1t s ignificantly 
reduce� the virus c irculation and the cl1n1cal presentation of the disease (Vann1er et





























tl1e number of cases. It does not matter if the vaccination does not cover I 00 per cent 
of the targeted population since the susceptible population tends to be smaller as the 
proportion of vaccinated animals grows (Anderson, 1992). 
When monitoring a vaccinated area, particular attention should be paid to 
major outbreaks, since minor outbreaks are less important for the dissemination of 
the virus (Van Nes, Stegeman, De Jong and others, 1996). The detection of minor 
outbreaks of AD is however, important for determining whether or not to stop 
vaccination. Only when the monitoring of the disease has been done regularly and the 
risk of infection has become very low. then it is recommended to stop vaccination 
(Stegeman, Elbers, Loefen and otliers, 1996; Vannier, Vedeau and Allemeersch, 
1997). 
The strategy based on the combination of vaccination and test and removal 
seems to be one of the best approaches in areas where the disease is endemic rather 
than a stam,ping-out policy, which is not economically advisable at present (Pensaert 
et al, 1990). 
The efficacy of vaccines has been assessed by the reduction of virus 
transmission by De Jong et til ( 1994). His results showed reduced virus transmission 
among�t pigs vaccinated with the 783 strain, compared to unvaccinated ones. 
However several studies have reported virus titres and duration of virus excretion 
after chaJlenge in vaccinated pigs (Mcferran, McCracken and Dow, 1982; Van 
O1rschoc et al. 1987; Pensaert et al, 1990)
It seems that the best immunogen 1s the wild-type virus since pigs recovered 
fron1 natural 1nfcct1on are resistant to experimental challenge unless a very high dose 
of virulent vjrus 1s applied by ON and intra-tracheal (IT) inoculations (Miry and
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In a coinparative study in which different types and methods of vaccination 
were studied, it was demonstrated that the most effectjve vaccine was the one based 
on ML V when administered IN. This was assessed by a measurable decrease in virus 
shedding and a milder clinical picture of the disease which was reflected in an earlier 
recovery of the affected animals (Menge]ing et al, 1992). Because the ON cavity is 
the most important natural route of infection for ADV, local levels of IgA might 
account for the superior performance of this method of vaccination, since intra­
muscular application does not trigger a significant nasal antibody response (Weigel et 
al, 1995). 
A comparison between inactivated and ML V vaccines using two applications 
of the former showed that inactivated vaccines were not effective in reducing virus 
excretion despite the fact that two inoculations were applied compared to a single 
shot of :t\1LV vaccines. However in spite of their cheaper price, MLV vaccines have 
not yet been widely accepted in some countries due to the fear recombination with 
\vild-type virus. The performance oiJ-in-water suspended and phosphate buffered 
sallne (PBS) vaccines \Vas compared, resulting in lesser amount and excretion of 
viru'<; with the former. This suggested that the vaccine vehicle plays a role in the 
immune response (Vannier et al, 1991; Pensaert et al, 1990). 
2.3.1. Vaccination schedules 
There arc 111any vaccination !)Chedules reported in the literature using d 1ff erent 
type of vaccines e.g. ML V or Killed, adJuvant phosphate buffered solution (PBS) or 
oil-in-water and different deleted protein�. The des 1gn 1ng of an ideal vaccination
programnie �hould take into account aspects related to the prevalence of the d 1�eru.e





























presence of virus circulation. Some programmes are designed to vaccinate just the 
breeding stock, others include also fattening pigs. The question is whether to apply 
one or two shots in the fattening ones. To this point Stegeman, Van Nes, De Jong and 
others (1995) reported that the incidence of infection in pigs vaccinated once was 
higher (38 per cent) than the incidence of pigs vaccinated twice ( I 0 per cent) giving 
values R0=3.4 and R0=1.5 respectively. Vannier et al (1991) argued that if vaccinated 
pigs were younger than 8 weeks of age a booster shot enhanced the immune 
response. 
2.3.2. Vaccination experiences in the control of ADV 
It seems that control of AD in large herds (>400 sows) requires the 
implementation of husbandry measures since simple application of vaccine is not 
enough to stop virus circulation. Field studies in large herds with high seroprevaJence 
of AD have reported considerable reduction and elimination of infected animals after 
J to 3 years of intensive vaccination programmes combined with changes in 
management (Lehman, Weigel, Seigel and others, 1993; Leh·man, Weigel, Seigel and 
others, l 994� Enge] and Weirup, 1989). However other studies in ende1n-1c areas have 
shown thaL even after intensive vaccination for as long as three years, viru& 
c1rculat1on was not fulJy stopped, since seropositive reactors being still detected. 
FortunJtely no major outbreaks were reported in such areas, indicating that 
vacc1nat1on reduced markedly the number of �uscept1ble an1maJ5 (Stegeman et al,
1996, Stegeman, Van O1rschot, K1m1nan and others, 1994; Van Nes, Stegeman, De 
Jong and otl1e1 s, 1997)
The hu�handry measures that help 1n the reduction of v1ru� c1rculat1on for the 





































reactors, offspring segregation with or without off-site rearing of rep]acement gilts. 
limited movements of pigs within the herd, reduced number of pigs per pen, and aJJ­
in-all-out pig flow practice. Any of these strategies may be applied together with 
vaccination (Hall et al, 1991 ). 
2.4. Diagnostic tests 
The diagnosis of a disease in an eradication campaign is crucial. 
A wide range of serological tests are available for detection of antibodies to 
ADV. Some of them are regarded as screening tests which detect antibodies to the 
whole virus, such as seroneutralisat1on (SN), enzyme-linked immunosorbent assay 
(ELISA), latex agglutination (LA), and particle concentration fluorescence 
immunoassay (PCFlA), whereas others as regarded as differential, based on ELISA 
which detect antibodies directed to a variety of ADV glycoproteins e.g. gl, gill or gX. 
Serological testing is the most suitable diagnostic procedure for eradication 
programmes of AD. The application current gene-deleted-vaccines enables the 
differentiation of the immune response of pigs to either the wild-type or vaccine 
virus, using the recently developed ELISA (gl) test (Van Oirschot, Rhiza, Moonen 
and others, 1986). 
A comparison between ELISA gl, conventional ELISA and two SN tests (SN 
lh and SN 24h) showed that the ELISA gl had as high sensitivity (99.2%) and 
specificity ( 100%) as the conventional ELISA; the two SN ( 1 and 24 h) had similar 
values for the�e parameters but the ELISA gI could detect a lower titre of antibodies
than the conventional ELISA The earliest test for detecting antibodies were the SN
te�t\ (7 dp1) cllld the latest the ELISA gJ (14 dpt) (Van Oirschot, 1991). ln 1981 Todd,

























between this test and a microtitre SN test indicated that the ELISA was more 
sensitive and detected antibodies earlier (7 d .pi) than the SN. The ELISA has shown 
some advantages such as being quicker and cheaper. Moreover it could be automated 
thereby, be s·uitable for testing large numbers of sera. 
The sensitive value for different differential ELISA tests was reported by 
White et al ( 1996) after 27 months of experimental infection (Table 6). 
Recently developed serological tests e.g. differential ELISA have supplanted 
SN tests which were regarded as the ugold" standard test for AD and demonstrated 
that they are equal or even 1nore sensitive. Nowadays, differential ELISA tests are 
available as commercial kits for testing thousands of samples for the monitoring and 
surveillance of AD \1/hich is fundamental in eradication programmes (Toma and 
Eloit, 1989). 
2.5. Epidemiological aspects 
2.5.1. Risk factors for the disease 
One of the basic principles in epidemiology is that diseases are not randomly 
distributed in a population since casual factors such as spatial, temporal and 
demographic characteristics are involved in determing the patterns of disease 
(Hungerford, 1991 ).
Ep1dem1ological studies have been focused on trying to 1dent1f y risk factors 
that play a role 1n the presentation and persistence of AD. The5e factor5 include
environmental conditions e.g. location, prevailing wind patterns and herd
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2.5.1.1 Geographical studies 
A region \Vith a low herd densily has beller chances to become free of the 
disease in a shorter penod of t ime than a region with high herd density (BuiJtels, 
Huirne, Dijkhu1zen and ot/1ers, 1997). 
Studies have found that herds located within an area with a low density of 
vacc inated herds are 2.7 times more likely to become infected than those herds 
located in an area with a higher density of vacc inated herds (Nonnan, Sischo, Pilcher 
and otliers, 1996), reflecting the importance of area vaccination in reduction of virus 
circulation since R0 lends to be lower in vaccinated herds (Smith 1990). 
Other studies have found that the proximity of a herd to a nver or Jake (within 
1 km) reduced the risk of infection [relative risk (RR=0.52)] while proximity to herds 
(within 5 km radius) practising farrow-to-finish and complete confinement (RR=2. l 2 
and 3.42, respectively) increased the risk of infection. These results suggested that 
more important risk factors were those related to herd type rather than environmental 
features (Marsh, Damrongwatanapokin, Lamtz and otliers, 1991 ). 
2.5.1.2. Characteristics of the herd 
There are herd factors already identified that have been related to ,rirus 
circulation, since these characteristics play an important role 1n the risk of a herd to 
become infected with AD. Amongst these factors concerning lo management 
practices are open or closed herds, herd type, and degree of confinement. Also f actor5 
such as pig density of certain area and the immune ';tatt1s of pigs 1nay interact one to 
each other to determine the dynamics of ADY. Indeed, 1l has been reported that the
mo5t important faclor5 for persistence of ADY are herd size and pig dens1Ly (Sn11th, 
1990). 
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The prevalence of the disease is regionally di�tr1buted since farms w1th high 
prevalence of the disease are clustered geographically as are farms with low 
prevalence. For example, it has been found that spread of AD was due to the 
proximity to an infected herd with high prevalence (28-30%) of the disease (Austin 
and Weigel, 1992). 
In a field survey carried out by Norman et al ( 1996) to identify risk factors for 
type of herd it was reported that the risk was 2.8 times more likely of becoming 
infected for a farrow to finish (FF) herd than the one for a f eeder-p1g-finish type. 
Another study found that the spread of ADV in breeding stock was 6.9 times 
more when the herd had common housing for gilts and sows together with a herd size 
of >400 sows and had constant seropositive finishing pigs (Duffy, Morrison and 
Thawley, 1991). 
Vaccinated herds are less likely to become infected but if so the amount of 
excreted virus tends to be lower in vaccinated herds than in unvaccinated ones. 
Therefore, a Ro value less than l can be expected, as was demonstrated by (Smith, 












Table I. Identified genes and biological characteristics of ADV glycoproteins. 




2H 686aa 84 
PK 336aa 41 
gX 498aa 99 
gp50 402aa 60 
gp63
350aa 63 
gl 577aa 110 
11K 106aa 11 
28K 256aa 28 
3
N .A= not applicable 
b= Not data available 




























































Table 3. Role of ADV proteins in immunogenecity and protection. 
Property 2I 211 2III 2X 21>50
MAbs neutralisea - + + - + 
MAbs neutralise+C' + + + - + 
Netralising activity in - -/+ + - + 
pig serumb
MAbs pig protectionc - + + - +
Antigen for 
B cells + + + + + 
Tc cells ? + ? - -. 
Induction of protection + ++e ++ - ++e 
3MAbs neutalised or did not neutralise ADV with or without complement. 









cMAbs protected or did not protect pigs against challenge. 
dProtein kinase and gp63 have not been reported as target antigens for antibodies of 
pigs . 
egll, gH IE and gp50 are essential for virus replication and thereby for the induction 
of immunity by live vaccines. 
Adapted from Van Oirschot et al, 1990, and Pensaert et al, 1992. 
Table 4. Detection of latenf infection with ADV by PCR in tissues collected by 
tonsillar biopsy at 12 weeks after vaccination and necropsy at 19 weeks after 
vaccination. 
No. of pigs I Tonsilar I Trigeminal ganglia I Olfactory I Tonsils 
• J 
bulbs 
16 3• 16 I 1 2 
10 0 10 1 1 
9 I 9 7 1 
10 0 9 1 0 
10 0 9 0 0 
Total 4 53 20 
No. of pigs 1n which PCR revealed ADY infection 
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Table 5. Deleted proteins in commercial AD vaccines. 
Gene deleted 
Vaccine gl gp63 gill gX TK 
Suvaxyn - + + + -
Nobi- - + + + -
Porvac 
Tolvid + + + - -
Omnimark + + - + -
PRV- + + + - -
marker 
Adapted from Wittmann, G. and Rziha, H. 1989. 
Table 6. Sensitivity of serologic tests for ADV. 
Test Sensitivity ( 100) 
Screenirzg 
SN (1 :2) 100.0 
SN ( 1 :4) 96.4 
ELISA (conventional) 100.0 
LA 100.0 
















3. MATERIAL AND METHODS
Information was collected from an existing database of the pig hea1th system 
(PHS) of the AD scheme officially running in Northern Ireland since September of 
1994. 
3.1. Background information of AD in Northern Ireland. 
A serological survey for AD took place in Northern Ireland between 31-01-93 
and 19-11-93. The sample included 2339 breeding sows from 187 herds, 6237 
fattening pigs, and 2327 culled breeding animals at slaughter. The survey revealed 
that 25% of farms, 13.5% of fattening pigs, 13.6% of culled breeding animals, and 
7.9% breeding animals were infected. The prevalence was higher in areas with higher 
pig density. 
3.2. Classification of herds. 
The AD scheme has classified the existing herds into three main categories 
according to their health status. The status of herd is given by the Department of 
Agr1culture based on all evidence available and in close collaboration with the 
farmer, private practitioner and DVO. The categories are:
I. OADF-Officially AuJeszky's disease-free is regarded as the highest health
�tatus where the following conditions have been met:
I .There are no pigs 1n the herd vaccinated against the disease 
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(a) two samplings of I 00 % of the breeding pigs by the conventional
ELISA(whole virus) between 6 to 8 months apart to achieve this health status; or 
(b) samples must be taken from 10% of all breeding pigs kept on the herd
subject to a minimum of 6 samples and a maximum of 40 at 6 monthly intervals in 
the first year after achievement OADF status and thereafter annually. The samples 
must be tested for the presence of antibodies to the whole virus with negative results. 
The sampling must include samples from at least two stock boars and from sows and 
gilts of different age groups and, in the case of a herd comprising more than one site, 
from all the sites where pigs are kept. 
(c) after the first two qualifying samplings only pigs from an OADF herd may
be moved into the herd. 
II. ADF-Aujeszky's disease-free and regarded as a middle health status where
the following conditions have been met: 
results; 
1 .All pigs kept on the herd must have been inoculated with deleted-vaccines. 
2.The breeding pigs must have undergone testing for AD with negative
(a) two samplings of 100% of the breeding pigs by the differential ELISA
(gE) between 6 to 8 months apart; 
(b) samples must be taken from l 0% of all breeding pigs kept on the holding
subJect to a mjnimum of 6 samples and a maximum of 40 at 6 monthly intervals in 
the f1r�t year after of granting ADF status and thereafter annually. The samples muc;;t 
be te�ted for antibodies to gE with negative results. The sampling n1ust include
sample� from at least two �tock boar!:> and from sows and gilts of different age groups
and, 1n the case of a holding compr1\ing more than one site, from alJ the site� where





















(c) after the first two qualifying samplings only pigs from an ADF or OADF
herd may be moved onto the herd 
ID. PS-Primary status is regarded as the lowest health status and is the initial 
category when a new herd is registered and included by the first time in the pig health 
system (PHS). The PS category is ctivided into subcategories as follows: 
PS*: downgraded herd but it may go up again. 
PS I: all tested pigs show evidence of vaccination but no evidence of 
infection. 
PS2: aJI tested pigs show evidence of vaccination and some evidence of 
infection. 
PS3: not all tested pigs show evidence of vaccination but not apparent 
infection. 
PS4: not evidence of vaccination but infected. 
PCA: not yet tested for antibodies, may have vaccinated pigs, candidate ADF 
(c ADF). 
PCO: not yet tested for antibodies, no vaccination, candidate OADF 
(c OADF). 
3.3. Movement control.
The pennitted movements of pigs vary according to the disease status of the 
herd and are identified by colour-coded documents as follows: OADF-green, ADF­
amber and PS-red. 
3.4. Vaccination schedule. 
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I 994, all the vaccines used for the purpose of eradication are gene gE-deleted­
vaccines (Bartha strain). Herds are required to be vaccinated as follows: 
-breeding stock, three times per year at 4 monthly intervals.
-fattening pigs and replacement breeding stock, at 10 and 14 weeks of age.
-breeding stock not previously vaccinated, twice 4 weeks apart and include
them in herd schedule thereafter. 
-pigs are not required to be vaccinated if they are kept either on OADF or
ADF herds or by officially exempted. 
3.5. Serological testing. 
Two ELISA tests are used for serological testing in Northern Ireland, one is 
used as a screening test (whole ELISA) developed at the Veterinary Sciences 
Division, Stormont, Belfast (NI) as described by Todd ( 1981) which detects 
antibodies either to wild-type virus or vaccine virus. Depending on the source of 
samples (OADF, ADF or PS herds) and the results of this first screening test, the 
samples can be tested by a second test which is differential ELISA (gE) (Herdcheck®, 
Idexx S.A. Cedex France). 
A positive reaction to the whole ELISA means that the sample has antibodies 
either to the wild-lype virus or vaccine virus. If the sample gives a negative reaction 
it means that the animal has no antibodies; in other words, the animal has not had 
contact with the virus and 1s regarded as free of infection. Positive samples shall be 
tested with the d1fferent1al ELISA (gE) 1n order to d1scrim1nate between wild-type 
viru\ and vaccine virus specific reaction. A po�1t1ve reaction to the ELISA (gE)
mean<; that the sample has ant1bod1es to the wild-type virus and then the pig 1s 





























All blood samples are tested by the Veterinary Services Division Stormont 
and are free of charge for the farmer. The blood samples are used for other survey 
e.g. transmissible gastro-enteritis (TGE) and porcine reproductive and respiratory
syndrome (PRRS). 
3.6. Pig health system (PHS)-ldentification of herds. 
All pig herds are required to be registered and issued with a licence by the 
Department of Agriculture. Herds are identified according to the DVO region, the 
identification denotes the region within which the herd is located. For example, UK 1 
ABC denotes a herd within division number 1 which is Armagh. Northern Ireland is 
divided into I O DVO regions (Appendix 1 ). 
3.7. Database. 
The PHS is a computed database for the administration of all herds and 







The 1nformat1on collected from the database for the analy51s in this 
d1�sertat1on was updated up to the 7th of August 1997.
Herds were examined by region, current status, herd type, and pig population. 

















health status, 667 records, and group B: herds that did not change their health status, 
840 records. 
For the analysis of the data herds within groups were also djvided into two 
groups according to their current health status: a) the group Others included: ADF, 
CA, CO, OADF, PCA and PCO herds (Appendix 2 describes current health status). 
These herds were neither vaccinated nor infected and were regarded as free from the 
disease since they had already stopped vaccination and were awaiting for a higher 
health status change. However herds could also be downgraded if seropositive 
animals were detected (it is important to have in mind that the scheme is a dynamic 
process). b) the group PS's included all PS subcategories: PS, PS*, PS 1, PS2, PS3 
and PS4 (Appendix 2). PS's herds were the target group to be compared with since 
they were the ones which are dealing either with the disease or vaccination. 
PS's herds were classified as follows: 
PS I: vaccinated, not infected. 
PS2: vaccinated, infected. 
PS3: not vaccinated, not infected. 
PS4: not vaccinated, infected. 
PS l +PS2: vaccinated 
PS3+PS4: not vaccinated 
PS I +PS3: not 1nf ected 
PS2+PS4: infected 
Stat1st1cal d1ff erence� between group A and group B, and group Otl,ers and 
group PS's, and PS's (one to each other) were looked at using non-parametric test�
(Ch1-\quare and Mann-Whitney) on Epi Info �oft.ware Version 6.











PS's, and PS's (one to each other) by the variables region, current status, and herd 
type from group A and group B respectively, and also for group A and group B
together. The numbers of observations in each group were pooled to avoid values <5 
in cells enabling the test to be valid. 
The pig population could not be analysed by para1netr1c test because the data 
showed a non-normal distribution. This variable was analysed by Mann-Whitney test 





4.1. Advances of AD scheme in Northern Ireland 
4.1.1. Figures of the pig population and its serologic condition reported from 
1994 to 1996. 
At the begin11ing of 1996 the pig population in Northern Ireland contruned 
700,000 pigs in 3,000 herds. The number of pig farms increased after the "BSE 
crisis", created a move from cattle farming into a pig farming, although the number 
of pigs remained almost the same. The number of farms increased from 2,733 by the 
end of 1994 to 3,707 by the end of 1996 (Table 7 and fig. I). 
The increment 1n the number of pig farms resulted in a bigger number of 
primary status (PS) since 1144 herds were classified as PS herds in 1994 compared to 
1536 at the end of 1996 giving a difference of 392 more herds. There was also a 
marked increase in OADF and ADF herds giving differences of 674 and 120 more 
herds respectively. This is explained by the reduction in the number of cOADF, PS/c 
OADF, cADF and PS/cADF herds respectively, since the dynamics of changing 
health status was attributable to the advances of the scheme (Table 7). 
The J1near regression was significantly different for the total number of herds 
(F==29. I, P<0.05), and the categories OADF (F=9 l .5, P<O.O I) and ADF herds 
(F== I 67 8, P<0.00 I) according to six monthly intervals. More herds appeared 1n both 
categories, although one increased more rapidly than the other (Table 7 and 7a).
The total number of PS herds by the end of 1996 was 1536. The d15tr1but1on 
of herds by region showed that the highest percentage of this herd category was
found in region UK J and UK3 folJowed by UK8. An est1mat1on of 288 infected















except in regions UK5 and UK9. 
The percentage of herds according to their serologic status showed an 
increase of OADF herds to 26 % by the end of 1996 compared to 2 % in 1994 which 
is attributable to a decrease of Candidate herds from 46 % to 13.3 % herds. The 
percentage of PS herds slightly increased from 51 % in 1994 to 56 % in 1996 as a 
result of the increase in total number of operational herds from 2242 in 1994 to 2725 
by the end of 1996 (Table 9 and fig 3). 
By the end of 1996 a total of 1536 herds were regarded as PS (including 
subcategories) herds which represented 56 % of the total number of operational herds 
(2725). Samples from 517 (33.6 % ) out of 1536 herds of this category were collected 
and examined, 134 were found infected (PS2 and PS4 together) which represented 
8.7 % of the total number of herds of this category. The remaining 1019 (66.4 % ) PS 
herds were not sampled (Table I 0, fig 4 and 4a). 
The seroprevalence of the disease decreased from 25 % to l 0. 7 % infected 
herds after two years since the AD scheme in Northern Ireland officially started. 
4.1.2. Analysis of group A and group B herds, and Others and PS's herds. 
4.1.2.1. Analysis by region. 
The d1stribulion of herds for group A by region showed that region UK8 had 
highest number of herds (nearly 200) representing 30 % of the total number of herds.
Regions UKl had J 54 and UK3 had I 05 herds representing 23. l % and 15.7 %
rc�pect1vely of the total of herds (Table 11, map 1 ).
The d1�tr1but1on of herds for group 8 showed that the h1ghe�t number of 
herds w� found 1n region UK4 with 21 J herds representing 25 1 % of the total
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21.0 % and l 2.5 % respectively of the total number of herds (Table 12, map I). 
4.1.2.2. Analysis of herds by current health status. 
The distribution of herds by current status of group A showed that 187 (28.0 
%) had PS3 status, 133 (19.9 %) had OADF status, and 97 (14.5 %) had PS 1 status 
(Table 13). 
The distribution of herds for group B, 359 ( 42. 7 % ) had PS status, 154 ( 18.3 
%) had PS3, and 109 (13.0 %) had PSl status (Table 14). 
4.1.2.3. Analysis of herds by region and current health status. 
The analysis of herds by region and current health status of group A from the 
three regions with the highest number of herds showed that 77.5 % of herds of region 
UK8, 63.8 % of herds of region UK3, and 62.3 % of herds of region UKI were PS's
herds (Tables 15 and 15a; map 2). 
Significant differences in the number of herds were found by chi-square test 
in the comparisons between the following groups: 
Others and PS's (x2=66.01, P<0.001) 
PSJ and PS2 (X2= 15.2; P<0.001) 
PSJ+PS3 and PS2+ PS4 (x2=14.69, P<0.001) 




PSJ+PS2 and PS3+PS4 (Table 15b). 








three region!) with the highest number of herds !)howed that 97. I % of herds of region 
UK3, 89.5 % of herds of region UK4, and 72 3 % of herd.s of region UK9 were PS's
herds (Tables 16 and 16a; map 2). 
Significant differences 1n the number of herds were found by chi-square test 
in the comparisons between the following groups: 
") 
Others and PS's (X .. =51.91, P<0.00 I) 
') 
PSJ and PS3 (x-=17.88, P<0.001) 
., 
PS2 and PS4 ex-=6.74, P<0.03) 
PSJ+PS2 and PS3+PS4 (X2=37.04, P<0.001) 
Conversely the comparisons were not significant between the groups: 
PS3 and PS4
PSJ+PS3 and PS2+PS4 (Table 16b). 
When group A a.nd group 8 were pooled and compared together significant 
differences in the number of herds were found by chi-square test for the comparisons 
between the groups: 
Otliers and PS's (X2=116.93, P<0.001) 
PSJ+PS2 and PS3+PS4 (X2=3.73, P<0.05) 
PSJ+PS3 and PS2+PS4 (X2=5.68, P<0.0 I) (Table 16c). 
Comparisons in the number of herds by chi-square test bet\veen the groups 
Otlzers and PS's of group A and group B inter-regionally sho\ved significant 
differences (P<0.05) for all the regions except those between the regions [UK0 and 
UK6], [UK2 and UKS], [UK2 and UK7], [UK2 and UK9], [UK6 and UK8], and 
[UK7 and UK9] (Table 17). 
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differences between the groups Otliers and PS's of group A and group B intra­
regionally as follows: 
') 
UK0 cx-=11.48, P<0.001) 
UK 1 (X2=6.93, P<0.003) 
UK3 (X2=62.29, P<0.001) 
UK4 (X2=7.38, P<0.01) 
UK6 (X2=5.27, P<0.02) 
') 
UK9 (x-=5.90, P<0.009) (Table 17). 
4.1.2.4. Analysis of herds by herd type. 
The analysis of herds by herd type of group A showed that only 348 (52. l %)
out of 667 records had recorded the herd type. The most common herd type was birth 
to weaning (BW) (Appendix 3 gives a description of herd types). There were 227 
BW herds (65.2 %) and 205 (90.3 %) of these were found within the group PS's.
Birth to bacon (BB) was the second most common herd type with 78 herds 
(22.4 %) of which 69 herds (88.4 %) belonged to PS's herds (Tables 18, 19 and 19a). 
The comparison between Otliers and PS's was not significantly different. 
The analysis of herds by herd type of group B showed that only 270 (32.1 % ) 
out of 840 records had recorded this variable. The most comn1on herd type was also
BW represented by 147 herds (54.4 % ) that had this herd type. Of these, 141 herds 
(95.9 %) belonged to the group PS's. Birth to bacon (BB) was the second most 
common herd type represented by 86 herds (31.9 % ) that had this herd type. Of these,
78 herds (90.6 % ) belonged to group PS's (Tables 20, 21 and 21 a).









4.1.2.5. Analysis of herds by pig population. 
The analysis of herds by pig popu]ation of group A revealed that the regions 
with the highest number of pigs were UKl with 37,611, UK8 with 31,744, and UK0 
with 22,749 pigs (Table 22). 
The analysis of herds by pig population of group B revealed that the regions 
with the highest number of pigs were UK4 with 52,628, UK3 with 27, I 02, and UK2 
with 22,828 pigs (Table 23). 
The intra-regional comparison of pig population by Mann-Whitney test 
between group A and group B showed significant differences only between regions 
UK1 (U=68.5, P<0.04), and UK6 (U=413, P<0.001). The remaining intra-regional 
compansons between group A and group B were not significant (Table 23a). 
The analysis of herds of group A showed similar pig population for the 
groups Others and PS's, being 90,353 and 99,573 pigs respectively. The pig 
population for the groups PS2, PS4 (infected herds), and PS herds was 12,666, 
11,488, and 9,725 pigs respectively (Table 24). 
The analysis of herds of group B showed a big difference of the pig 
population for the groups Otliers and PS's, being 8,473 and 136,95 I pigs 
respectively. The pig population for the groups PS2, PS4 (infected herds), and PS
































No.herds No.herds Difference 
06/96 10/96 from 
12/94 to 
10/96 
619 719 674 





1193 1536 392 
987 982 491 
3257 3707 
Table 7a. Linear regres&ions on months for totaJ nu1nber of herds, and the categories 
OADF, ADF and PS herds. 
Regression N 





* Jo very �1gn1ficant 





Y=60.4 + 3 I .4X
Y=l .5 + 5.8X
Y=1156 + I0.9X
41 
F p Interpretation 
29. l <0.05 * 
91.5 <0.01 *it:
167.8 <0.00 l *** 
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Table 8. Number and proportion of PS herds by region serologicaJly tested and 
infected by the end of 1996. 
Region %of No.of herds % Herds infected Total number of Estimated 
PS blood from 1996 survey PS herds within number of 
herds surveyed 1993 i,z brackets Division infected 
during 1996 herds 
UKO 32o/o 14 21% [28%] 103 22 
UKl 70% 49 22% (31 %] 222 48 
UK.2 58% 21 9.5% [18%] 109 10 
UK3 70% 71 24'fo [28%] 325 78 
UK4 43% 72 29% [33%] 207 60 
UK5 45% 7 57% [22%] 45 26 
UK6 46% 22 4.5% [15%] 120 5 
UK7 57'fo 20 30% [ 44 o/o] 52 16 
UK8 60% 30 3.3% [19%] 261 9 
UK9 37% 20 15% [11%] 92 14 







































































































































































































































Table 9. Proportion of herds according to their serologic status from 1994 to 1996. 
Health status % herds 12/94 % herds 12/9 5 % herds 10/96 
OADF 2% 23% 26% 
ADF 0 4o/o 3% 4.7% 
Candidate 46% 29o/o 13.3% 
PS 51% 54% 56% 




















































































































Table 10. Number and percentage of the condition of PS subcategory herds. 
PS herds= 1536 Total 
PS Subcategories 
PSI PS2 PS3 PS4 
Vaccination + + - -
Infection - + - + 
Percentage 34 4% 13% 39.6o/o 13% 
of herds 











































































































































































































































































































































































































Table 11. Number and proportion of herds of group A by region.
Region Number of herds Poportion 
within the 
region 
UKO 89 13.3 % 
UKl 154 23.1 % 
UK2 9 1.3 % 
UK3 105 15.7 % 
UK4 5 0.7 % 
UKS 1 0.1 % 
UK6 84 12.6 % 
UK7 8 1.2 % 
UK8 200 30.0 % 
UK9 12 1.8 % 
Total 667 100 % 
Table 12. Number and proportion of herds of group B by region. 
Region Number of herds Proportion 
within the 
region 
UKO 21 2.5 % 
UKl 6 0.7 % 
UK2 90 10.7 % 
UK3 176 21.0 % 
UK4 211 25.1 % 
UKS 52 6.2 % 
UK6 28 3.3 % 
UK7 52 6.2 % 
UK8 99 11.8 %
UK9 105 12.5 % 


































































































































































































































































































































































































































































































































Table 13. Number and proportion of herds of group A by current health status. 
Current health Number of herds Proportion 
status 
ADF 42 6.3 % 
CA 12 1.8 % 
co 44 6.6 % 
OADF 133 19.9 o/o 
PCA l 0.1 % 
PCO 4 0.6 o/o 
PS 33 4.9 o/o 
PS* 42 6.3 % 
PSI 97 14.5 % 
PS2 32 4.8 % 
PS3 187 28.0 'fo 
PS4 40 6.0 % 
Total 667 100 % 
Table 14. Number of herds of group B by current health status. 
Current health Number of herds Proportion 
status 
ADF 0 0 
% 
CA 13 1 5 'fo 
co 43 
5 ) 'fo 






PS 35 9 
42.7 'fo 
PS* 15 
) 8 % 
PSI 109 































Table 15. Number of herds of erouo A b - J .� � - - -- --- . 
Current health status 
Ree1on ADF CA co OADF PCA PCO PS PS• PSl PS2 PS3 PS4 Totnl 
UKO 7 7 13 29 0 0 4 0 4 8 12 5 89 
UK.J 13 I 12 29 0 3 14 37 14 6 20 5 154 
0 0 0 I 0 0 0 0 3 I 4 0 
UKJ 7 2 3 26 0 0 I I 14 7 37 7 105 
UK4 1 1 0 I 0 0 I 0 I 0 0 0 5 
UKS 0 0 I 0 0 0 0 0 0 0 0 0 1 
UK6 9 0 0 15 0 0 4 2 I I 2 33 8 84 
UK7 0 0 I I 0 0 0 0 0 I 4 I 8 
UK8 5 I 10 27 I I 9 2 49 7 75 13 200 
UK9 0 0 4 4 0 0 0 0 I 0 2 I 12 
Total 24 12 44 133 1 4 33 42 97 32 187 -10 667 
Table 15a. Number and proportion of herds of the groups Others and PS's of group 
A bv region and 
. . 
Current health status 
Otliers
1
PS PS* PSI PS2 PS3 PS4 Total TOTAL Region 
(%) (o/n) (9'o) (�) (%) (o/o) (%) PS's
2 
(%} 
UKO 56 (62 9) 4 (4 4) 
UKl 58 (37 6) 14 (9.0) 
UK2 I (II I) 0 
UK3 JR (161) I (0 9) 
UK4 3 (60 0) I (20)
UKS I (100) 0 
UK6 22 (26 I) 4 (4.7) 
UK7 2 (25) 0 
UK8 ./5 (22.5) 9 (4.5) 
UK9 R (66 6) 0 
Totru 216 (35 3) 33 (4.9) 
0 4 (4 4) 
37 (24 0) 14 (9 0) 
0 3 (33 3) 
I (0.9) 14(133) 
0 I (20)
0 0 
2 (2 J) 11 (13.0) 
0 0 
2 ( I 0) 49 (24 5) 
0 I (8 3) 
42 (6 2) 97 ( 14 5) 
8 (8 8) 
6 
( I I I) 
I 
( I I I ) 
7 (6 6) 
0 
0 
2 (2 3) 
I 
( 12 5) 
7 (1 5) 
0 
32 (4 7) 
12 (13 4) 
20 ( 12 9) 
4 (•W 4) 
37 ()5 2) 
0 
0 
33 (39 2) 
4 (50)
75 (]7 5) 
2 ( I 6 6) 
187 (28 0) 
Otlzers include ADF, CA, CO, OADF, PCA and PCO herds.
-ps':, include PS, PS*, PS 1, PS2, PS3 and PS4 herd<;.
5 (5 6) 33 (37 0) 89 
5 (12) 96 (62.3) 154 
0 8 (8H 8) 
7 (6 6) 67 (63.8) 105 
0 2 (.JOO) 5 
0 0 I 
8 (9 5) 62 (73 8) 84 
I ( 12 5) 6 (75 OJ 
13(6'i) /55 (77 5) 200 
I (8.:\) ., (33 3) 12 
40 ('i 9) ./3/ (64 6) 667 
Table 15b. P values of the comparison 1n the numbers 
of herds by region and currenl
health !)tJ.tu� between the groups Otliers and PS's,
 and PS's (one to each other) of




chi 66.0 I 
square 
df 5 
p 0.00 I 
..... 
*** ext:remel)' significant 








Herd type comparison 
PS3 PSI PS2 PSl+PS2 PSl+PS3 
and and J.nd and and 
PS4 PS3 PS4 PS3+PS4 PS2+PS4 
2 46 615 4 87 
5 98 14 69 
4 4 3 
5 4 
0 65 0.18 0 18 
018 0 001 
NS NS NS 
N� ·� '
53 
reoion nd curr nt h ~ Ith t~tu 
-
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Table 16. Number of herds of group B by region and current health status. 
Current health status 
Region ADF CA co OADF PCA PCO PS PS• PSI PS2 PS3 PS4 Total 
UKO 0 1 3 0 0 0 17 0 0 0 0 0 21 
UKI 0 0 0 0 0 6 0 0 0 0 0 0 6 
UKl 0 0 0 0 0 1 30 2 26 4 21 6 90 
UK3 0 1 2 0 0 2 34 2 32 17 63 23 176 
UK4 0 6 9 0 0 7 100 1 32 26 22 8 211 
UK5 0 1 3 0 0 10 22 1 3 0 11 1 52 
UK6 0 0 0 0 0 1 23 0 2 0 2 0 28 
UK7 0 1 1 0 2 I 22 l I 2 14 7 52 
UK8 0 0 14 0 0 5 73 4 1 0 2 0 99 
UK9 0 3 11 0 0 15 32 4 12 2 19 7 105 
Total 0 13 43 0 2 42 359 15 109 51 154 52 840 
Table 16a. Number and proportion of herds of the groups Others and PS's of group 
B by region and current health status. 
Current health status 
Region Others 1 PS PS* PSI PS2 PS3 
{%) (%) (%) {%) {%) (%) 
UKO 4 (190) 17 (80 0) 0 0 0 0 
UK! 6 (100 0) 0 0 0 0 0 
UK2 I (] /) 30 (33.3) 2 (2 2) 26 (28 8) 4 (4 4) 21 (23.3) 
UK3 2 (2 8) 34 ( 19 3) 2 ( I I) 32 (16 5) 17 (9.6) 63 (35.7) 
UK4 22 (JO 4) 100 (47 3) l (0 4) 32 (15 l) 26 22 ( 10 4) 
(12 3) 
UKS 1../ (26 9) 22 (42 3) I (l 9) 3 (5 7) 0 11 (21 1) 
UK6 1 (3 5) 23 (82 I) 0 2 (7 1) 0 2 (7 1) 
UK7 5 (9 6) 22 (42 3) 1 (l 9) 1 (I 9) 2 (3 8) 14 (26.9) 
UK8 /9 (/9 /) 73 (73 7) 4 (4 0) I (1 0) 0 2 (2 0) 
UK9 29 (27 6) 32 (30 4) 4 (3 8) 12 (11 4) 2 ( 1 9) 19 ( 18 0) 
TotaJ JOO (1 I 9) 359 (42 7) 15 ( I 7) 109 ( 12 9) 51 (6 0) 154(18 3) 
I 
� 
Others include: ADF, CA, CO, OADF, PCA and PCO herds. 
2





0 17 (80 0) 
0 0 
6 (6 6) 89 (98.8) 
23 ( 13 0) 171 (97 J J 
8 (3 7) 189 (89 5) 
1 (I 9) 38 (73 OJ 
0 27 (96 ./) 
7 (13 4) ./7 (90 3)
0 80 (80 8) 
7 (6 6) 76 (72 3) 
52 (6 I) 740 (88 0) 
Table 16b. P values of the comparison in the number of herds by region and current
health status between the groups Otliers and PS's, and PS's (one to each other) herds
of group B bv chi sauare test ' 
,J -, 
Values Or/1ers PSJ 
and and 
PS's PS2 
chi square 5 I 91 6 50 
df 5 2 
p 0.001 0.03 
•--ie * 
Herd type comparison 
PS3 PSI PS2 
and and and 
PS4 PS3 PS4 
0.34 17.88 6 74 
4 4 2 
0 98 0 001 0.03 
NS 
*** • 





37 04 6 48 
4 4 
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• . I 
I 
.. 
NS non significant 
Table 16c. P values of the comparison in the number of herds by current health 
status between the groups [Otliers and PS's], [PSl+PS2 and PS3+PS4], and 
[PS 1 +PS3 and PS2+PS4] of group A and Group B together by chi square test. 






Herd tvoe comoarison 




















Table 17. Comparison in the number of herds by current heaJth status between the 
groups [Otliers and PS's] inter-regionally (one to each other), and intra-regionally of 
group A and group B by chi square test. 




























Region �roup B 
UK3 UK4 UKS 
*** *** *** 
*** *** *** 
*** ** NS 









*** extremely significant 
NS non significance 
Cl> difference between [Otl,ers and PS's] intra-regionally
57 
UK6 UK7 UKS UK9 
NS *** *** *** 
*** *** *** *** 
*** NS *** NS 
*** *** *** *** 
*** *** *** *** 
*** ** *** ** 

































Table 18. Number and proprotion of herds of group A by herd type. 
Herd ty_pe Number of herds Proportion 
A 4 1.1 % 
BB 78 22.4 % 
BBW 5 1.4 % 
BW 227 65.2 % 
F 34 9.8 % 
Total 348 100 % 
Herd type:A= Alterer or Improver, BB= Birth to Bacon, BBW= Birth to Bacon sells 
weaners, BW= Birth to Weaning, F= Fattener. 
Table 19. Number of herds of group A by current health status and herd type. 
Herd type 
Cument 
status A BB BBW BW F Total 
ADF 0 0 0 I 
0 1 
CA 0 1 0 1 
0 
co 0 8 0 
17 3 28 
OADF 0 0 0 I 
0 1 
PCA 0 0 0 
0 0 0 
PCO 0 0 I 
2 1 4 
PS 0 9 0 
I 1 1 21 
PS* 0 13 0 
22 1 36 
PSl I 12 I 
60 3 77 
PS2 0 4 0 
15 I 20 
PS3 3 27 3 
77 22 132 
PS4 0 4 0 
20 ') 26 -
TOTAL 4 78 s 
227 34 348 
Herd type:A= Alterer or Improver, BB= Birth to Bacon, BBW= Birth to Bacon sel1s
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Table 19a. Number and proportion of herds of the groups Others and PS's of group 
A by current health status and herd type. 
Herd lype 
Currrent 
status A(%) BB (%) BBW (%) BW(%) 
Ot'1ers
1
0 9 (1/.5) 1 (20) 22 (9.6) 
PS 9 ( 11.5) 0 11 (4.8) 
PS* 0 13 ( 16 6) 0 22 (9 6) 
PSl 1 (25) 12 (15 3) I (20) 60 (26.4) 
PS2 0 4 (5.1) 0 15 (6.6) 
PS3 3 (75.0) 27 (34.6) 3 (60) 77 (33.7) 
PS4 0 4 (5.1) 0 20 (8.8) 




69 (88.4) 4 (80) 205 (90.3) 
TOTAL 4 78 5 227 
1
Otlzers include: ADF, CA, CO, OADF, PCA and PCO herds. 
2
PS's include: PS, PS*, PS 1, PS2, PS3 and PS4 herds. 
F (%) Total ( o/o) 
4 ( 11. 7) 36 ( 10.3) 
l (2.9) 21 (6.0) 
] (2.9) 36 ( I 0.3) 
3 (8.8) 77 (22.1) 
I (2.9) 20 (5 7) 
22 (64.7) 132 (37.9) 
2 (5.8) 26 (7.4) 
30 (88.2) 312 (89.6) 
34 348 
Herd type:A= Alterer or Improver, BB= Birth to Bacon, BBW= Birth to Bacon sells 
weaners, BW= Birth to Weaning, F= Fattener. 
59 
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Table 20. Number and proportion of herds of group B by herd type. 
Herd type Number of herds Proportjon 
1 0.4 % 
BB 86 31.9 % 
BBF 1 0.4 % 
BBW 3 I .1 % 
BW 147 54.4 % 
F 30 11.1 % 
PD 1 0.4 % 
SD 1 0.4 % 
Total 270 100 % 
Herd type:A= Alterer or Improver, BB= Birth to Bacon, BBW= Birth to Bacon selJs 
weaners, BW= Birth to Weaning, F= Fattener, PD= Dealer Production Pigs, SD= 
Dealer (Sows). 
Table 21. Number of herds of group B by current health status and herd type. 
Herd type 
Current A 8B BBF BBW BW F PD SD TOTAL 
health 
status 
ADF 0 0 0 0 0 0 0 0 0 
CA 0 2 0 0 I 0 0 0 3 
co 0 3 0 0 I 
I 0 0 5 
OADF 0 0 0 0 0 0 0 0 0 
PCA 0 0 0 0 I 0 0 
0 l 
PCO 0 3 0 0 3 0 
0 0 6 
PS 0 2 0 0 8 0 
0 0 10 
PS* 0 2 0 0 2 
0 0 0 4 
PSI 0 19 0 0 40 
9 I 0 69 
PS2 0 I 1 0 0 13 
2 0 0 26 
PS3 1 36 1 2 56 10 
0 0 106 
PS4 0 8 0 I 22 8 
0 I 40 
TOTAL 1 86 1 3 147 
30 l l 270 
Herd type:A= Alterer or Improver, BB= Birth to Bacon, BBW= Birth to Bacon sells
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Table 21a. Number and proportion of herds of groups Otlzers and PS's of group B 
by current health status and herd type. 
Herd tyoe 
Currrent A BB BBF BBW BW F PD SD 
health {%) {%) (%) (%) {%) (%) (%) (%) 
status 
Others
1 0 8 (9 3) 0 0 6 (4 0) l (3 3) 0 0 
PS 0 2 (2 3) 0 0 8 ( 12 2) 0 0 0 
PS* 0 2 (2 3) 0 0 2 (I 3) 0 0 0 
PSI 0 19 (22.0) 0 0 40 (27 2) 0 (30 0) l ( I 00 0) 0 
PS2 0 11 ( 12 7) 0 0 13 (8 8) 2 (6 6) 0 0 
PS3 1 ( 100 0) 36 (41 8) 1 ( 100 0) 2 (66 6) 56 (38 0) 10 (33 3) 0 0 
PS4 0 8 (9 3) 0 I (33.3) 22 (14 9) 8 (26 6) 0 I (100.0) 
Total 1(100 0) 78 (90 6) 1(100 0) 
PS's
2 (%) 
3(100 0) 141(95 9) 29 (96 6) 1(100 0) l ( JOO 0)
Total 1 86 1 3 147 30 1 1 
1Others include: ADF, CA, CO, OADF, PCA and PCO herds. 




JO (3 9) 
4 ( I 5) 
69 (25 5) 
26 (9 6) 




Herd type:A= Alterer or Improver, BB= Birth to Bacon, BBW= Birth to Bacon sells 















Table 22. Pig population of group A by region. 
Region 
Herds1ze UKO UK1 UK2 UK3 UK4 UK5 UK6 UK? UK8 UK9 
Mean 385.6 255 9 185 6 276.1 106 356 1 192 172 5 24 1 
Median 36 74 97 63 78 1 80 5 15 30 10 5 
Range 1-3282 1-1756 9-491 1-1938 58-422 1 1-516 5-41 1-2118 2-73 
Sum 22749 37611 1299 20709 558 1 28135 154 31744 193 
N 59 147 7 75 3 1 79 8 184 8 
Table 23. Pig population of group B by region. 
Region 
UKO UK1 UK2 UK3 UK4 UK5 UK6 UK? UK8 UK9 
Mean 93 6 13 7 300 4 334 6 378 6 127.9 40 2 131 1 136.8 193 7 
Median 56 5 12 52 70 81 12 24 25 31 23.5 
Range 1-1-741 2-27 1-2804 2-4056 1-9999 1-1800 1-300 1-2155 1-2647 1-3349 
Sum 690 41 22828 27102 52628 6395 803 6425 10674 17918 
N 7 3 76 81 131 50 20 49 78 92 
Table 23a. Intra-regional comparison of the pig population of group A and group B 
by Mann-Whitney test. 
Value UKO UK1 UK2 
s and and and 
UKO UK1 UK2 
Mann 230.5 68.5 246 
Whit 
ney 












UK4 UK5 UK6 UK? UK8 UK9 
and and and and and and 
UK4 UK5 UK6 UK? UK8 UK9 
1830 - 413 156.5 6938 258.5 
0.72 - 0.001 0.37 0.79 0.16 
NS -

















Table 24. Pig population of group A by current health status. 
Current health status 
ADF CA co OADF PCA PCO PS PS* PS1 PS2 PS3 PS4 Others PS's 
Mean 512.4 464.5 117 2 164 7 459.5 184 9 324 1 264.2 208.6 469 1 237 4 337.9 
Median 212 157.5 35 52 200 5 65 86.5 79 21 105 44 5 55.5 
Range 5-3282 1-3282 2-1628 1-2156 5-1756 1-2156 1-1963 31756 1-2181 3-2000 1-4500 1-
5116 
Sum 19984 8361 8670 19434 20219 13685 9725 10040 18145 12666 37509 11488 90353 99573 
N 39 18 74 118 44 74 30 38 87 27 158 34 367 374 
Table 25. Pig population of group B by current health status. 
Current health status 
ADF CA co OADF PCA PCO PS PS* PS1 PS2 PS3 PS4 Others PS's 
Mean 238.5 130 6 21 58.6 139 7 339 5 248.4 419 8 369.2 570 9 
Median 52 33 21 16 29 129 52 88 5 55 73 5 
Range 10- 1-1223 13-29 1-708 0-3549 16- 1-4742 3-2804 1-4056 7-9999
1174 1970 
Sum 2624 4050 42 1757 32551 4413 22105 15954 41357 20551 8473 136951 
















The purpose of this study was to investigate the progress of the AD scheme 
running officially in Northern Ireland from September 1994, and to analyse the 
difference between herds by region, current health status, herd type and pig 
population. 
The progress of the AD scheme in Northern Ireland was measured by increase 
in the number of herds through the time. More herds having high health status have 
been increased progressively every six months (Tables 7 and 7a). The significant 
difference of the linear regression for the high health status (OADF, ADF) support 
this. However, the PS herds have increased their number as well which means that 
more new herds have joined the scheme; unfortunately no sarnpling enough has been 
practised in such herds because the "BSE crisis". In other words, more herds had 
higher health status in 1996 than before in 1994 which means that the worry of 
getting AD disease in pig operations has decreased; otherwise, farmers would be 
reluctant to get into the pig industry, but it might be coupled to the fact of the "BSE 
crisis" which created a change into pig farming rather than cattle farming.
The main significant differences in the number of herds were the comparisons 
between the groups 1) Otliers and PS's, 2 )PSl+PS2 and PS3+PS4, and 3 )PS l+PS3
and PS2+PS4 (Table 16c). Jn other words, there were significant differences 1n the
number of herds between I) free herds and non-free herds, 2) vaccinated herds and
non-vaccinaced herds, and 3) infected herd', and non-infected herd<; in group A and
group B when compared together The re�ults were expected and are s1m1lar to those 
reported dtfference5 between \ acc1nated and non-vaccinated herds (Thawley and





































In contrast, significant comparisons were only detected between Otliers and 
PS's when group A and group B were compared separately. The other comparisons 
\Vere not consistent since the comparison between PS' s ( one lo each other) resulted in 
a cross-over difference. Unexpectedly, the comparison between PS 1 +PS3 and 
PS2+PS4 was significantly different for group A whereas the same comparison was 
not significant in group B. Consequently the interpretation is confused and requires 
more attention. 
UK3 and UK4 which share borders were the most important regions in terms 
current health status and pig population since half of PS2 and PS4 (infected) herds 
were found 1n these two regions, specially in region UK3. The infected herds are 
geographically clustered creating high pig density areas that facilitates the spread of 
the disease (Weigel, Austin, Seigel and others, 1992; Norman et al, 1996; Austin et
al, 1992; Auvigne and Hery, 1997). Airborne transmission of AD has to be taken into 
account 1n eradication programmes, speciaJly in areas with high density and high 
prevaJence of the disease (Scheidt, Reuff, Grant and others, 1991 ). This can be 
applied to the fact that regions UK3 and UK4 share borders and belong to the main 
pig production area of Northern Ireland where aerosol transmission might be possible
bet\veen them.
BW being the mosl co1nmon herd type has the advantage of rearing fewer 
pig!) on the same site, reducing the chances of virus circulation in fattening pigs
because p1g') are sold at weaning. This hmitates the size and compos1t1on of the
\U\cept1ble population (Leont1des, Ewald. Morten�en and otherJ, 1995) Fu rlher
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studies should be done to identify if seropositive pigs belong to either the breeding 
stock, or fattening pigs, or both. On the other hand, BW has the disadvantage of 
increasing the chances of infection by pig movements when weaners are sold, since 
22 % of these herds were regarded as infected. Other control measures together with 
vaccination should be practised to prevent reintroduction of virus from outside, for 
instance pig movement control (Stegeman, 1997). 
Infected herds had a mean pig population not greater than 571 pigs and were 
located basically in two regions. However, Bouma, De Jong and Kimrnan (1995) 
believed that the transmission of AD did not depend on herd size and they postulated 
that the virus might even spread in small populations. 
An association between the spread of AD among breeding pigs and the 
presence of non-vaccinated pigs has been reported (Duffy et al, 199 l; Morrison, 
Marsh, Anderson and others, 199 l). The number of infected, unvaccinated herds 
reported in this study was 92 of which 41 % were found in regions UK3 and UK4. 
This could be a point to take into account to encourage the vaccination of these 
herds. 
More attention should be focused on PS herds since no antibody testing has 
been done so far. This i� important to detennine their proper current health status
since there 1s a con�1derable number (392) of herds which represents l 0.7% of the
total number of herds of which 37% were found in regions UK3 and UK4. PS herds
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Further studies should be done based on economical aspects, taking into 
account the prevalence of the disease, the distribution of infected herds, and the 
willingness of producers who own free AD pig fanns to pay compensation of 
infected herds. Having found that infected herds are located mainly in a certain area, 
it would be helpful to determine what is more economically feasfbJe whether to appJy 
a stamping out policy or to keep on with the vaccination strategy. 
The procedure of antibody testing of the AD scheme in Northern Ireland is 
based on testing the positive samples to the whole ELISA with one differentiaJ 
ELISA (gE). If these positive samples give a positive result to the ELISA (gE) then 
they are tested again. In other countries such as the Netherlands seropositive sera to 
the ELISA (gE) are tested again twice using two different commercial ELISA (gE) 
tests to verify the positive reactors (Van Nes et al, 1997). This laboratory strategy is 
to be recommended in eradication programmes when the prevalence of the disease 1s 
low and the diagnosis requires to be more precise. 
The AD scheme in Northern Ireland has the advantage of being financially 
supported by the State which provides the antibody-testing free of cost for producers 
\Vhereas in other European countries such as Sweden pig producers have to bear the
co�t5 of getting an AD free status (Engel et al, 1989).
The database currently used 1n the erad1cat1on programme of the disease 1n 
Northern Ireland 1s efficient since it 1s regularly updated, and every pig herd in the




















programme. However, it has to be improved in terms of having a bigger set of 
records of herd characteristics, since for instance, only 51 % and 32 % of herds of 
group A and group B respectively had recorded the herd type. The same gap of 
records may also be app.lied to pig population. This m_ight be useful for further 
epidemiological studies to identify the risk factors of AD in Northern Ireland. 
The current eradication scheme in Northern Ireland is making progress since 
the prevalence of the disease has dropped from 25 % to I 0.7 % infected herds after 
two years of the compulsory vaccination programme. Sim_ilar results of an area-wide 
(96 km2) intensive vaccination programme in the Netherlands also reported a marked 
reduction of the prevalence after two years using similar vaccination schedule 
(Stegeman et al, 1997). However, failure in the eradication of the disease using a 









AD is an important disease affecting the good performance of the pig 
production in many countries. Few countries have achieved eradication whereas 
many others are currently applying programmes to eradicate the disease. The scheme 
in Northern Ireland has made progress. 
One of the major obstacles to clean AD from pig farms is the fact that ADY 
causes latent infections which are not clinically manifested from which the virus can 
be reactivated under certain conditions. 
The development of gene-deleted vaccines coupled with the complementary 
serologic tests which differentiate vaccinated from infected pigs are very good tools 
for monitoring the progress achieved in eradication programmes. Vaccination against 
AD is the main control measure applied in several countries which are trying to 
eradicate the disease 
Risk factors related to the presentation and perpetuation of ADY infection 
include environmental and herd characteristics features that interact together making 
more difficult the control of the disease. 
The disLribution of AD in Northern Ireland showed that the disease was more 
frequenL 1n regions UK3 and UK4. More than 50 % of the infected herds were
located 1n these t\vo regions. 
The AD eradication scheme in Northern Ireland had the advantages of dealing 
Wtth a considerable low prevalence of the disease and ptg population, regionally
limited 1nfect1on, positive attitude of pig producers, and official f und1ng support.
These facts. coupled with accurate d1agnost1c tests and n1arker vacc1ne5 that enable
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Appendix 2. Current health status classification. 
ADF: Aujeszky's disease free. 
CA: candidate ADF. 
CO: candidate OADF. 
OADF: officially Aujeszky's disease free. 
PCA: not yet tested for antibodies, may have vaccinated pigs, candidate ADF. 
PCO: not yet tested for antibodies, no vaccination, candidate OADF. 
PS: default status when a herd is registered and no information of its health status is 
known. 
PS*: downgraded herd but it may go up again. 
PS 1: all tested pigs show evidence of vacccination but no evidence of infection. 
PS2: all tested pigs show evidence of vaccination and some evidence of infect1on. 
PS3: not all tested pigs show evidence of vaccination but not apparent infection. 
PS4: not evidence of vaccination or infection. 
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Appen dix 3. Herd type clas si fic ation.
A A lte rer or Improver 
BB Birth to Ba c on
BBF Birth t o  Ba con buys Wean ers
BBW Birth t o  Ba c o n  sells weaners
BW Birth to Wean
i
ng
F F att ener 
PD Dealer Production Pi gs
s
o Deal er (S ows)
8
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